| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/17/2003 | WO2003030904A1 8-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid amide |
| 04/17/2003 | WO2003030902A1 Imidazole derivates as anti-inflammatory agents |
| 04/17/2003 | WO2003030898A1 Modulators of ccr5 chemokine receptor activity |
| 04/17/2003 | WO2003017927A3 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 04/17/2003 | WO2002069968A8 New use |
| 04/17/2003 | WO1999067238A3 Tetrahydroquinoline-indole derivatives antimicrobial agents, their uses and compositions containing them |
| 04/17/2003 | WO1999064401A3 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 04/17/2003 | US20030073839 Compounds useful for preparation of Beta-3 adrenoreceptor agonist |
| 04/17/2003 | US20030073717 Therapy for nervous system disorders; anxiolytic agents; anticonvulsants |
| 04/17/2003 | US20030073699 Compounds and methods to treat cardiac failure and other disorders |
| 04/17/2003 | US20030073691 Antitumor agents; anticancer agents |
| 04/17/2003 | US20030073690 Controlling pain in mammals |
| 04/17/2003 | US20030073687 Alzheimer's disease; anticancer agents; antidiabetic agents |
| 04/17/2003 | US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/17/2003 | US20030073678 Vanadium compounds for treating cancer |
| 04/17/2003 | US20030073668 Antiproliferative agents; anticarcinogenic agents; viricides |
| 04/17/2003 | US20030072763 Absorb in the low- energy, ultraviolet, visible, or near-infrared (NIR) region of the electromagnetic spectrum that are used for the phototherapy of tumors and other lesions |
| 04/17/2003 | CA2462806A1 8-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylic acid amide |
| 04/17/2003 | CA2462801A1 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists |
| 04/17/2003 | CA2459727A1 4-haloethenylphenyl tropane: serotonin transporter imaging agents |
| 04/17/2003 | CA2458456A1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 04/17/2003 | CA2458453A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 04/16/2003 | EP1302472A1 Molecules capable of binding to telomere and the like and method with the use of the same |
| 04/16/2003 | EP1302462A1 Sulfone derivatives, process for their production and use thereof |
| 04/16/2003 | EP1302458A1 Ester derivatives |
| 04/16/2003 | EP1301514A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 04/16/2003 | EP1301510A1 New bispidine compounds and their use in the treatment of cardiac arrhythmias |
| 04/16/2003 | EP1301493A2 Heterocycle carboxamides as antiviral agents |
| 04/16/2003 | EP1301487A2 Viral polymerase inhibitors |
| 04/16/2003 | EP1301464A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments |
| 04/16/2003 | EP1102769B1 Tricyclic carboxamides |
| 04/16/2003 | EP1075478B1 Phenylurea and phenylthio urea derivatives |
| 04/16/2003 | EP0972769B1 Novel amide derivatives and medicinal compositions thereof |
| 04/16/2003 | CN1411460A Substituted homopiperidinyl benzimidazole analogues as fundic relaxants |
| 04/16/2003 | CN1411459A Compound and method for treatment of pain |
| 04/16/2003 | CN1411458A Saccharin derivatives as orally active elastase inhibitors |
| 04/16/2003 | CN1411444A Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 04/16/2003 | CN1410059A Treating method and medicine kit containing somatotrophic hormone secretory agent |
| 04/16/2003 | CN1105723C Spirocyclic metalloprotease inhibitors |
| 04/16/2003 | CN1105715C New pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising same as active ingredient |
| 04/15/2003 | US6548668 Stabilizer for proteins |
| 04/15/2003 | US6548524 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 04/15/2003 | US6548506 1-substituted,3-carboxy,7-fluoro,8-disubstituted amino-1,4-dihydrobenzo(b)(1,8)naphthyridin-4-ones; Useful as antimicrobial agents; topical antibiotic for wounds |
| 04/15/2003 | US6548502 Preventing disorder selected from pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction such as drug and alcohol and sex in a mammals by administering pyrido(1,2-a) pyrazine derivatives |
| 04/15/2003 | US6548501 Composition and methods for stimulating gastrointestinal motility |
| 04/15/2003 | US6548496 Substituted 3-cyano-[1.7], [1.5], and [1.8] naphthyridine inhibitors of tyrosine kinases |
| 04/15/2003 | US6548493 Substituted heterocycle fused gamma-carbolines |
| 04/15/2003 | US6548079 Moxifloxacin formulation containing common salt |
| 04/15/2003 | US6547395 Methods of measuring moving objects and reducing exposure during wavefront measurements |
| 04/15/2003 | CA2259698C Trovafloxacin mesylate tablet |
| 04/15/2003 | CA2070573C Derivatives of amide analogs of certain methano bridged quinolizines |
| 04/11/2003 | WO2004096982A2 Antibacterial agents |
| 04/10/2003 | WO2003029340A2 Fluorescent pigment composition |
| 04/10/2003 | WO2003029252A1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease |
| 04/10/2003 | WO2003029247A1 N-heterocyclyl hydrazides as neurotrophic agents |
| 04/10/2003 | WO2003029225A1 Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them |
| 04/10/2003 | WO2003029224A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029216A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003029211A1 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 04/10/2003 | WO2003029210A2 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 04/10/2003 | WO2003028733A1 Tetracyclic indole derivatives as 5-ht receptor ligands |
| 04/10/2003 | WO2003028729A2 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | WO2003028728A1 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands |
| 04/10/2003 | WO2003028725A1 4-(1-piperidiny)-butylcarboxamide as d3 dopamine receptor subtype selective ligands |
| 04/10/2003 | WO2003028724A1 Chk1 kinase inhibitors |
| 04/10/2003 | WO2003028721A2 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 04/10/2003 | WO2003028641A2 Mch receptor antagonists |
| 04/10/2003 | WO2003028459A1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 04/10/2003 | WO2003004493A8 Novel compounds, their preparation and use |
| 04/10/2003 | WO2003002974A3 Ecl labels having improved non-specific binding properties, methods of using and kits containing the same |
| 04/10/2003 | WO2002102793A3 Quinazolinediones as antibacterial agents |
| 04/10/2003 | WO2002094830A8 Dihydropyrrolo[1,2-a]indole and tetrahydropyrido[1,2-a]-indole derivatives as prostaglandin d2 receptor antagonists |
| 04/10/2003 | WO2002071827A3 Retinoid x receptor modulators |
| 04/10/2003 | WO2002059083A3 Novel compounds |
| 04/10/2003 | WO2001072748A9 Imidazopyridin-8-ones |
| 04/10/2003 | US20030069430 Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects |
| 04/10/2003 | US20030069424 Indolylmaleimide derivatives |
| 04/10/2003 | US20030069417 Reacting 2-amino-3-hydroxymethyl pyridine with N-methyl-1-phenyl-2,2'-iminodiethyl chloride to form 1-(3-hydroxymethylpyridyl-2-yl)-4-methyl-2-phenyl-piperazine, and then reacting with ring closing agent to form mirtazepine |
| 04/10/2003 | US20030069294 Alpha-substituted carboxylic acid derivatives |
| 04/10/2003 | US20030069272 Prevent joint stiffness; adjust concentration of synovial fluid |
| 04/10/2003 | US20030069271 Quinolone compounds for use in treating viral infections |
| 04/10/2003 | US20030069269 Tropane analogs and methods for inhibition of monoamine |
| 04/10/2003 | US20030069266 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 04/10/2003 | US20030069261 Therapy for eating disorders, sexual disorders, psychological disorders |
| 04/10/2003 | US20030069257 Benzimidazole and pyridylimidazole derivatives |
| 04/10/2003 | US20030069249 Analgesics; central nervous system disorders |
| 04/10/2003 | US20030069248 Antiinflammatory agents; controlling cell cycle |
| 04/10/2003 | US20030069245 Aids therapy |
| 04/10/2003 | US20030069240 Skin disorders; food allergies |
| 04/10/2003 | US20030069237 Nitrogen containing heterobicycles as factor Xa inhibitors |
| 04/10/2003 | US20030069234 CXCR3 antagonists |
| 04/10/2003 | US20030069230 Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists |
| 04/10/2003 | US20030069226 Benzothiazole or benzothiazine derivatives of dipyrido(3,2b:2',3'-e)(1,4-diazepin-6-one |
| 04/10/2003 | CA2462647A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2462601A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2462419A1 N-heterocyclyl hydrazides as neurotrophic agents |
| 04/10/2003 | CA2462305A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 04/10/2003 | CA2461976A1 Aryl ether derivatives and processes for their preparation and herbicidal and desiccant compositions containing them |
| 04/10/2003 | CA2460594A1 Mch receptor antagonists |
| 04/10/2003 | CA2453343A1 Tetracyclic indole derivatives as 5-ht receptor ligands |